CLPUB00500
Collins J.K., O'Mahony A., O'Brien F., Corbett A., Morrissey D., O'Donoghue M., O'Sullivan G.C.
Evaluation of newly established cell lines as models to study growth, invasion and metastatic spread in oesophageal cancer.
Fibrinolysis 6 Suppl. 4:83-88(1992)

PubMed=10390151; DOI=10.1023/A:1026470417680
Morrissey D., O'Connell J., Lynch D., O'Sullivan G.C., Shanahan F., Collins J.K.
Invasion by esophageal cancer cells: functional contribution of the urokinase plasminogen activation system, and inhibition by antisense oligonucleotides to urokinase or urokinase receptor.
Clin. Exp. Metastasis 17:77-85(1999)

PubMed=11297525; DOI=10.1074/jbc.M010847200
Barry O.P., Mullan B., Sheehan D., Kazanietz M.G., Shanahan F., Collins J.K., O'Sullivan G.C.
Constitutive ERK1/2 activation in esophagogastric rib bone marrow micrometastatic cells is MEK-independent.
J. Biol. Chem. 276:15537-15546(2001)

PubMed=26512696; DOI=10.3390/cancers7040881; PMCID=PMC4695881
O'Callaghan C., Fanning L.J., Barry O.P.
Hypermethylation of MAPK13 promoter in oesophageal squamous cell carcinoma is associated with loss of p38delta MAPK expression.
Cancers (Basel) 7:2124-2133(2015)